Dr. Guillermo (Gary) Tearney is the Remondi Family Endowed MGH Research Institute Chair, Professor of Pathology at Harvard Medical School, an Affiliated Faculty member of the Harvard-MIT Division of Health Sciences and Technology (HST) and maintains his lab at the Wellman Center for Photomedicine at the Massachusetts General Hospital. Prof. Tearney received his MD magna cum laude from Harvard Medical School and received his PhD in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology. He is a fellow of the American College of Cardiology (ACC), College of American Pathologists (CAP), National Academy of Engineering (NAI), Optical Society of America (OSA), and the American Institute for Medical and Biological Engineering (AIMBE). Dr. Tearney’s research interests are focused on the development and clinical validation of non-invasive, high-resolution optical imaging methods for human disease diagnosis. Dr. Tearney’s lab was the first to perform human imaging in the coronary arteries and gastrointestinal tract in vivo with Optical Coherence Tomography (OCT), which provides cross-sectional images of tissue architectural microstructure at a resolution of 10 µm. He has also conducted many of the seminal studies validating OCT and is considered an expert on OCT image interpretation. Recently, Dr. Tearney’s lab has invented a next generation OCT technology, termed µOCT, which has a resolution of 1 µm and is capable of imaging cells and subcellular structures in the body. Dr. Tearney is one of the 2022 DF/HCC Incubator Award winners for his work on the ‘Assessment of novel technologies for early detection of cancer in individuals with germline cancer predisposition’ team.
